2 published test results across 1 vendor · latest: 24 Sept 2026
The published record here covers 1 vendor and 2 recorded tests, which is what the rankings above are built from.
SLU-PP-332 is an estrogen-related receptor agonist from the newest wave of exercise mimetics, with rodent endurance data and nothing else. It is about as early-stage as anything sold in this market.
Dosing volumes are arithmetic; the peptide calculator handles them. Whether the vial matches its label is a testing question.
Nothing on this page is medical advice; compounds shown are sold for research purposes only. Data is aggregated from publicly published third-party results and traces to its source.